Plant Cell and Tissue Differentiation and Secondary Metabolites: Fundamentals and Applications
Abstract
Plant cell and tissue cultures are indispensable tools to understand the process of differentiation that has become a powerful technology for commercial level production of micropropagated plants. Various technological innovations in growing and analyzing cell cultures have led to the production of useful primary and secondary metabolites from plant cell cultures using bioreactors up to a 75,000 L capacity. The processes of differentiation as well as production of secondary metabolites are complex, both involving a coordinated expression of several genes. Differentiation of cells and tissues causes qualitative and quantitative changes in the production of secondary metabolites. Metabolomics and transcriptome analysis of cells and tissues will provide more insight into genes K. G. Ramawat (*) Department of Botany, University College of Science, M. L. Sukhadia University, Udaipur, Rajasthan, India e-mail: [email protected]; [email protected] © Springer Nature Switzerland AG 2021 K. G. Ramawat et al. (eds.), Plant Cell and Tissue Differentiation and Secondary Metabolites, Reference Series in Phytochemistry, https://doi.org/10.1007/978-3-030-30185-9_35 1 involved in biosynthesis of secondary metabolites. In this brief overview, process of differentiation of cells, tissues, and organs and production of secondary metabolites as affected by plant cell and tissue differentiation are presented. The importance of unorganized and organized cultures as production system is also…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.